The recent decision by the German Federal Joint Committee (G-BA) to relax the requirement for prior approval from health insurers for certain medical cannabis prescriptions, expected to take effect in two months, marks a significant shift in the cannabis industry. Should the G-BA’s proposals be approved by the Ministry of Health, an estimated more than […]
Germany is currently engaged in a critical dialogue about reforming pharmacy services, especially in rural areas affected by widespread personnel shortages. Do you think that this is a chance for the German society, facing those discussions now, rather that later? What would be the downside when it comes to “asking your local pharmacist”, exchanged by
The Current Debate and Reforms in Germany’s Pharmacy Coverage Read More »
Introduction For startups aiming to introduce a new high-margin cannabis strain in Germany, leveraging the influence of popular personalities can be a game-changer. Understanding consumer preferences, consumption patterns, and desired effects is crucial for creating a brand that resonates with the market and achieves high profitability. This article provides key insights and strategies to help
The discourse surrounding the marketing of pharmaceutical products, particularly cannabis, has taken center stage in the pharmaceutical sector, revealing a complex landscape where legal restrictions, cultural perceptions, and patient needs converge. Co-Founder of thermidor< Dave Barton’s observations highlight a pivotal point of contention: the audacious, sometimes rule-defying, tactics some companies employ to market their products.
